[HTML][HTML] Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala, B Cai - BMC Infectious Diseases, 2022 - Springer
Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou… - BMC infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning pathogen
in the USA and worldwide. Methods To assess the comparative burden of CR vs …

[HTML][HTML] Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou… - BMC Infectious …, 2022 - bmcinfectdis.biomedcentral.com
Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning pathogen in the USA
and worldwide. To assess the comparative burden of CR vs carbapenem-susceptible (CS) …

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019.

JM Pogue, Y Zhou, H Kanakamedala… - BMC Infectious …, 2022 - europepmc.org
Methods To assess the comparative burden of CR vs carbapenem-susceptible (CS) A.
baumannii, this retrospective cohort study analyzed data from adult patients in 250 US …

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala, B Cai - 2022 - deepblue.lib.umich.edu
Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019.

JM Pogue, Y Zhou, H Kanakamedala, B Cai - 2022 - cabidigitallibrary.org
Abstract Background: Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods: To assess the comparative burden of CR vs …

[HTML][HTML] Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala… - BMC Infectious …, 2022 - ncbi.nlm.nih.gov
Methods To assess the comparative burden of CR vs carbapenem-susceptible (CS) A.
baumannii, this retrospective cohort study analyzed data from adult patients in 250 US …

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019.

JM Pogue, Y Zhou, H Kanakamedala… - BMC Infectious Diseases, 2022 - go.gale.com
Methods To assess the comparative burden of CR vs carbapenem-susceptible (CS) A.
baumannii, this retrospective cohort study analyzed data from adult patients in 250 US …

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala… - BMC Infectious …, 2022 - search.proquest.com
Methods To assess the comparative burden of CR vs carbapenem-susceptible (CS) A.
baumannii, this retrospective cohort study analyzed data from adult patients in 250 US …

[PDF][PDF] Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala, B Cai - 2022 - bmcinfectdis.biomedcentral.com
Abstract Background: Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods: To assess the comparative burden of CR vs …